Počet záznamov: 1
Fate of human mesenchymal stem cells (MSCs) in humans and rodents-Is the current paradigm obtained on rodents applicable to humans?
Názov Fate of human mesenchymal stem cells (MSCs) in humans and rodents-Is the current paradigm obtained on rodents applicable to humans? : letter to the editor Autor Lakota Ján 1959- SAVBIOMED ; SAVEXONK ; SAVNOPAT - Biomedicínske centrum SAV SCOPUS RID ORCID Zdroj.dok. Journal of cellular and molecular medicine. Vol. 22, no. 4 (2018), p. 2523-2524 Jazyk dok. eng - angličtina Druh dok. rozpis článkov z periodík (rbx) Ohlasy LU, Guanming - LI, Yueyong - MA, Yanfei - LU, Jinlan - CHEN, Yongcheng - JIANG, Qiulan - QIN, Qiang - ZHAO, Lifeng - HUANG, Qianfang - LUO, Zhizhai - HUANG, Shiqing - WEI, Zhongheng. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. In JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, vol. 37, no., pp. Dostupné na: https://doi.org/10.1186/s13046-018-0945-6. AZADBAKHT, Narjes - DOOSTI, Abbas - JAMI, Mohammad-Saeid. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. In BIOLOGICAL PROCEDURES ONLINE, 2022, vol. 24, no. 1, art. no. 8. Dostupné na: https://doi.org/10.1186/s12575-022-00171-1. JAVADI, M. - SAZEGAR, H. - DOOSTI, A. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells. In BMC CANCER. NOV 27 2023, vol. 23, no. 1, art. no. 1155. Kategória GII - Rôzne publikácie a dokumenty, ktoré nemožno zaradiť do žiadnej z predchádzajúcich kategórií Rok vykazovania 2018 Registrované v WOS Registrované v CCC DOI 10.1111/jcmm.13561 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2018 2017 4.302 Q1 1.647 Q1
Počet záznamov: 1